Lipocine Inc. (LPCN)
NASDAQ: LPCN · IEX Real-Time Price · USD
7.56
-0.16 (-2.07%)
At close: Jul 2, 2024, 4:00 PM
7.93
+0.37 (4.89%)
After-hours: Jul 2, 2024, 6:19 PM EDT
Lipocine Market Cap
Lipocine has a market cap or net worth of $40.43 million as of July 2, 2024. Its market cap has increased by 59.80% in one year.
Market Cap
40.43M
Enterprise Value
15.80M
1-Year Change
59.80%
Ranking
Category
Stock Price
$7.56
Market Cap Chart
Since October 22, 2013, Lipocine's market cap has increased from $35.00M to $40.43M, an increase of 15.52%. That is a compound annual growth rate of 1.36%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 1, 2024 | 41.30M | 179.05% |
| Dec 29, 2023 | 14.80M | -57.95% |
| Dec 30, 2022 | 35.20M | -59.77% |
| Dec 31, 2021 | 87.50M | -2.02% |
| Dec 31, 2020 | 89.30M | 811.22% |
| Dec 31, 2019 | 9.80M | -64.87% |
| Dec 31, 2018 | 27.90M | -61.73% |
| Dec 29, 2017 | 72.90M | 8.48% |
| Dec 30, 2016 | 67.20M | -71.53% |
| Dec 31, 2015 | 236.00M | 250.67% |
| Dec 31, 2014 | 67.30M | -26.21% |
| Dec 31, 2013 | 91.20M | 160.57% |
View and export this data all the way back to 2013.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BioLineRx | 47.03M |
| Bionano Genomics | 46.99M |
| vTv Therapeutics | 45.80M |
| Clene | 45.58M |
| Envoy Medical | 45.52M |
| Daxor | 45.08M |
| BioXcel Therapeutics | 45.04M |
| Augmedix | 44.57M |